Logo image of PAE

PAE INC (PAE) Stock Fundamental Analysis

NASDAQ:PAE - Nasdaq - Common Stock

10.05  +0.01 (+0.1%)

After market: 10.05 0 (0%)

Fundamental Rating

1

Taking everything into account, PAE scores 1 out of 10 in our fundamental rating. PAE was compared to 65 industry peers in the Aerospace & Defense industry. PAE has a bad profitability rating. Also its financial health evaluation is rather negative. PAE has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year PAE was profitable.
PAE Yearly Net Income VS EBIT VS OCF VS FCFPAE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 0 20M 40M 60M 80M 100M

1.2 Ratios

Industry RankSector Rank
ROA 2.83%
ROE 45.14%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
PAE Yearly ROA, ROE, ROICPAE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 0 2 4 6 8 10

1.3 Margins

Industry RankSector Rank
OM 3.48%
PM (TTM) 1.73%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
PAE Yearly Profit, Operating, Gross MarginsPAE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 5 10 15 20

More info and screens

1

2. Health

2.1 Basic Checks

PAE has more shares outstanding than it did 1 year ago.
PAE has a worse debt/assets ratio than last year.
PAE Yearly Shares OutstandingPAE Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 20M 40M 60M 80M
PAE Yearly Total Debt VS Total AssetsPAE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 500M 1B 1.5B

2.2 Solvency

An Altman-Z score of 2.24 indicates that PAE is not a great score, but indicates only limited risk for bankruptcy at the moment.
A Debt/Equity ratio of 7.59 is on the high side and indicates that PAE has dependencies on debt financing.
Industry RankSector Rank
Debt/Equity 7.59
Debt/FCF N/A
Altman-Z 2.24
ROIC/WACCN/A
WACCN/A
PAE Yearly LT Debt VS Equity VS FCFPAE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 200M 400M 600M 800M

2.3 Liquidity

PAE has a Current Ratio of 1.25. This is a normal value and indicates that PAE is financially healthy and should not expect problems in meeting its short term obligations.
PAE has a Quick Ratio of 1.25. This is a normal value and indicates that PAE is financially healthy and should not expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 1.25
Quick Ratio 1.25
PAE Yearly Current Assets VS Current LiabilitesPAE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 200M 400M 600M

More info and screens

3

3. Growth

3.1 Past

PAE shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -21.61%.
The Revenue has grown by 54.30% in the past year. This is a very strong growth!
EPS 1Y (TTM)-21.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%181.82%
Revenue 1Y (TTM)54.3%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%3.5%

3.2 Future

The Earnings Per Share is expected to grow by 26.16% on average over the next years. This is a very strong growth
PAE is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.87% yearly.
EPS Next Y104.4%
EPS Next 2Y25.39%
EPS Next 3Y34.28%
EPS Next 5Y26.16%
Revenue Next Year12.63%
Revenue Next 2Y4.53%
Revenue Next 3Y6.24%
Revenue Next 5Y4.87%

3.3 Evolution

PAE Yearly Revenue VS EstimatesPAE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 1B 2B 3B
PAE Yearly EPS VS EstimatesPAE Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 18.96, PAE is valued on the expensive side.
The average S&P500 Price/Earnings ratio is at 26.55. PAE is valued slightly cheaper when compared to this.
With a Price/Forward Earnings ratio of 19.90, PAE is valued on the expensive side.
PAE's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 22.40.
Industry RankSector Rank
PE 18.96
Fwd PE 19.9
PAE Price Earnings VS Forward Price EarningsPAE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 10.25
PAE Per share dataPAE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as PAE's earnings are expected to grow with 34.28% in the coming years.
PEG (NY)0.18
PEG (5Y)N/A
EPS Next 2Y25.39%
EPS Next 3Y34.28%

More info and screens

0

5. Dividend

5.1 Amount

PAE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

PAE INC

NASDAQ:PAE (2/14/2022, 4:12:28 PM)

After market: 10.05 0 (0%)

10.05

+0.01 (+0.1%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)11-04 2021-11-04
Earnings (Next)03-10 2022-03-10/bmo
Inst Owners0.81%
Inst Owner Change0%
Ins Owners0.69%
Ins Owner Change0%
Market Cap935.86M
Analysts75
Price Target11.86 (18.01%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 18.96
Fwd PE 19.9
P/S 0.31
P/FCF N/A
P/OCF N/A
P/B 8.21
P/tB N/A
EV/EBITDA 10.25
EPS(TTM)0.53
EY5.27%
EPS(NY)0.51
Fwd EY5.02%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS31.93
BVpS1.22
TBVpSN/A
PEG (NY)0.18
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.83%
ROE 45.14%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 3.48%
PM (TTM) 1.73%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover1.63
Health
Industry RankSector Rank
Debt/Equity 7.59
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.25
Quick Ratio 1.25
Altman-Z 2.24
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-21.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%181.82%
EPS Next Y104.4%
EPS Next 2Y25.39%
EPS Next 3Y34.28%
EPS Next 5Y26.16%
Revenue 1Y (TTM)54.3%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%3.5%
Revenue Next Year12.63%
Revenue Next 2Y4.53%
Revenue Next 3Y6.24%
Revenue Next 5Y4.87%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A